Latest posts tagged with #ASH2024 on Bluesky
🩸 Don’t miss the Upstate NY Hematology & Hematologic Oncology Conference, hosted by Roswell Park!
🔬 Review the latest from #ASH2024 with local + national experts.
➡️ Register now: registration.onclive.com/upstate-new-...
#PublicaSalutIB 🩸🏥 Els serveis d'hematologia dels hospitals Son Espases, Son Llatzer, Hospital de Manacor i @idisba.bsky.social varen participar al 66 ASH Annual Meeting www.infosalut.com/investigacio/estudis-i-p...
#ASH2024 #66ASH2024 #Hematologia
#PublicaSalutIB 🩸🏥 Els serveis d'hematologia dels hospitals Son Espases, Son Llatzer, Hospital de Manacor i @idisba.bsky.social varen participar al 66 ASH Annual Meeting www.infosalut.com/investigacio/estudis-i-p...
#ASH2024 #66ASH2024 #Hematologia
Mark your calendars for #ASH2024 review organized by Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center at The Peabody Memphis on 3/27/25. Our 🌟 speakers: Jeremy Pantin, Minoo Battiwalla, @krishpatelmd.bsky.social & Stephen Strickland. See👇 for RSVP info.
What are some of the new therapies discussed at #ASH2024?
Watch the video: sohoinsider.com/news/what-ar...
with @amydezern.bsky.social and Drs. Tiffany Tanaka, Uma, Borate, & Guillermo Garcia-Manero
One of the big bonuses of my job is that I get to travel to awesome events like #ASH2024. Here is the ASH recap from me and a few colleagues - www.thermofisher.com/bindingsite/...
#Hematology #MultipleMyeloma
Myeloma UK was at #ASH2024 here's some of the things we learned and how it will impact our work going forward. www.myeloma.org.uk/news/ash2024... #myelomasky #myeloma #MGUS #SmoulderingMyeloma
This New Year, think about fitness — but not just at the gym!
Researchers such as @DrJoeScandura are developing tools to track how #MPN cells are more “fit” and outcompete healthy ones. #ASH2024 presentations showed progress toward using fitness as a biomarker.
Avapritinib Yields Improvements in Bone Density in Advanced Systemic Mastocytosis
@ash.hematology.org @danafarbernews.bsky.social #ASH2024
www.onclive.com/view/avaprit...
The #ASH2024 spotlight shone on MPNRF-funded research from the Royston Lab! @DJ_Royston
Using spatial transcriptomics & AI, they revealed how MPNs are associated with widespread disruptions in bone marrow cellular architecture.
#MPNResearch
Dr. @bkmarcellino 's presented the results of the 2020 MPN Progression Pilot grant exploring TP53 disruption at her #ASH2024 presentation, bridging early ideas with new therapeutic possibilities. PPM1D + HDM2 inhibitors are now in the spotlight. Proof that funding bright minds fuels progress.
A Big Ten CRC trial, BTCRC-LUN20-462, was presented as a poster presentation at #ASH2024 in December 2024.
Congratulations to Vaishalee Kenkre, MD, of UW Carbone Cancer Center, Andrew M. Evens, DO, MBA, MSc, of @rutgerscancer.bsky.social & all co-authors!
Read more: bigtencrc.org/btcrc-lun20-...
Do we think me including the X-ray of my distal fib fracture from falling down the stairs leaving my house on my way to #ASH2024 will help getting the “Even More Space” seat upgrade reimbursed? 🤔
Luspatercept/Lenalidomide Combo Demonstrates Safety and Early Efficacy in Lower-Risk, Non-Del(5q) MDS @mikkaelsekeres.bsky.social @ash-hematology.bsky.social #ASH2024 #mpnsm #oncology www.onclive.com/view/luspate...
Second-Line Axi-Cel Is Efficacious, Safe in Real-World Patients With R/R LBCL @ash-hematology.bsky.social #ASH2024 #lymsm #oncology www.onclive.com/view/second-...
As I reflect on my experiences at #ASH24 / #ASH2024, I'd like to share some personal highlights. I promise that they're not all the jokes on the mirrors. Although I did love them and will add them to my stash of jokes.
These views are my own and not necessarily those of my employer. (1/?)
Triplet combination regimens demonstrate high response rates in multiple leukemias - ASH
@mdanderson.bsky.social
@nitinjainmd.bsky.social
oncodaily.com/science/ash-...
#AML #ASH2024 #AUGMENT101 #Cancer #Leukemia #OncoDaily #Oncology #SAVEtrial #Medicine #Health #TripletCombinationRegimens
Learn about the results of a phase II trial of triplet therapy for CLL using acalabrutinib, venetoclax, and obinutuzumab in this video from @ash-hematology.bsky.social 2024 with Matthew S. Davids, MD, MMSc of @danafarber.bsky.social.
ascopost.com/videos/2024-...
#CLL #ASH2024 #leusm
🧑⚕️ Découvrez le replay de notre dernière webconférence de l'année !
Le Pr. J-J Kiladjian - @jjk04.bsky.social a fait le point sur les annonces en matière de recherche sur les NMP, suite au congrès annuel de l’ASH !
youtu.be/tnzCxgTxKdo?...
#npmsm
#Hematology
#ASH2024
@ash Recap 2023: Cutting-edge science dazzled, but advocacy fell short. Nonprofits deserve center stage, not the sidelines. Let’s push for progress in 2025! 🩸🤝 #ASH2024 #PatientAdvocacy #WeCanDoBetter
www.linkedin.com/posts/matthe...
Learn all about the potential for serial monitoring of graft-versus-host disease symptom severity in this video from @ash-hematology.bsky.social 2024 featuring Nikolaos Katsivelos, MD, and John Levine, MD, MS.
ascopost.com/videos/2024-...
#ASH2024 #GVHD
Impatient de partager avec les patients les dernières nouveautés présentées au congrès américain d’hématologie la semaine dernière #ASH2024 @ash-hematology.bsky.social
In this video from @ash-hematology.bsky.social 2024, Danielle Wolfe Cohen, MD, discusses research into an inflammatory phenotype in driving clonal evolution in B-cell acute lymphoblastic leukemia.
ascopost.com/videos/2024-...
#ash2024 #leusm #leukemia
Great to see you all here. Could you please share the most important news of #ASH2024. This year I could not join
I caught covid at #ASH2024. Anyone else? Exactly six months after catching it at ASCO. My doctor gave me a flu booster a couple weeks ago and I assumed since they didn't offer covid I was up to date. I am now!
MD Anderson Research Highlights: ASH 2024 Special Edition
@mdanderson.bsky.social
@ash-hematology.bsky.social
oncodaily.com/insight/md-a...
#AML #ASH2024 #AxiCel #Cancer #Luspatercept #Health #MyeloidNeoplasms #OncoDaily #Oncology #Medicine #SickleCellDisease #Vibecotamab #ZUMA5Trial
AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients
@abbvie.bsky.social
@ash-hematology.bsky.social
oncodaily.com/blog/abbvie-...
#AbbVie #ASH2024 #Cancer #CLL #EmotionalImpactReport #MentalHealth #OncoDaily #Oncology #PatientCare #PatientAdvocacy
